<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>PENDING</status><version>v2</version><patient-age>54</patient-age><report-id>PHHO2011AR021780</report-id><gender>female</gender><reactions><reaction>Cardiac arrests</reaction><reaction>Aspiration pneumonia</reaction><reaction>Septic shock</reaction><reaction>Urinary tract infection</reaction><reaction>Bacteremia</reaction><reaction>Left frontal Ischemic stroke due to heart disease (mitral regurgitation)</reaction><reaction>Renal dysfunction possibly due to dehydration/ Renal disfunction</reaction><reaction>Renal dysfunction possibly due to dehydration</reaction><reaction>Acute tubulointerstitial nephritis (moderate)</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>MYFORTIC</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name> PROGRAF</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>NEORAL </drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>Renal transplant</indication></indications><outcomes><outcome>Death</outcome><outcome>Life Threatening</outcome><outcome>Required Inpatient Hospitalization</outcome></outcomes><country>Argentina</country><geo/></meta><original><ichicsr lang="en" xmlns="">
	<ichicsrmessageheader>
		<messagetype>ichicsr</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>4053232_286</messagenumb>
		<messagesenderidentifier>NovartisPH</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20121211134656</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>4</safetyreportversion>
		<safetyreportid>PHHO2011AR021780</safetyreportid>
		<primarysourcecountry>AR</primarysourcecountry>
		<occurcountry>AR</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>2012-12-11</transmissiondate>
		<reporttype>2</reporttype>
		<serious code="1">Yes</serious>
		<seriousnessdeath>1</seriousnessdeath>
		<seriousnesslifethreatening>1</seriousnesslifethreatening>
		<seriousnesshospitalization>1</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>1</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>2011-12-30</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>2012-12-10</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>1</fulfillexpeditecriteria>
		<companynumb>PHHO2011AR021780</companynumb>
		<medicallyconfirm>1</medicallyconfirm>
		<primarysource>
			<reportertitle>Dr.</reportertitle>
			<reportergivename>Rafael</reportergivename>
			<reporterfamilyname>Maldonado</reporterfamilyname>
			<reporterstreet>Rafael de Igarzabal N 967</reporterstreet>
			<reportercountry>AR</reportercountry>
			<qualification code="1">Physician</qualification>
			<sponsorstudynumb>CRAD001A2429</sponsorstudynumb>
			<observestudytype>1</observestudytype>
		</primarysource>
		<primarysource>
			<reportergivename>Marisol</reportergivename>
			<reporterfamilyname>Rodrievez</reporterfamilyname>
			<reporterstreet>Rapal de Igarzabal N 967</reporterstreet>
			<reportercountry>AR</reportercountry>
			<qualification code="3">Other Health Professional</qualification>
			<observestudytype>1</observestudytype>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>NOVARTIS PHARMACEUTICAL CORPORATION</senderorganization>
			<senderdepartment>Clinical Safety and Epidemiology</senderdepartment>
			<senderfamilyname>Clinical Safety and Epidemiology</senderfamilyname>
			<senderstreetaddress>Novartis Pharmaceuticals Corp. Bldg 419, One Health Plaza</senderstreetaddress>
			<sendercity>East Hanover</sendercity>
			<senderstate>NJ</senderstate>
			<senderpostcode>07936</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<sendertel>+1800378</sendertel>
			<sendertelextension>8567</sendertelextension>
			<sendertelcountrycode>US</sendertelcountrycode>
			<senderfax>+1973781</senderfax>
			<senderfaxextension>8001</senderfaxextension>
			<senderfaxcountrycode>US</senderfaxcountrycode>
			<senderemailaddress>gdss.configuration@pharma.novartis.com</senderemailaddress>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receiverdepartment>FDA</receiverdepartment>
			<receivertitle>Mr</receivertitle>
			<receivergivename>William</receivergivename>
			<receiverfamilyname>Taylor</receiverfamilyname>
			<receiverstreetaddress>5600 Fishers Lane Room 16B-45</receiverstreetaddress>
			<receivercity>Rockville</receivercity>
			<receiverstate>MD</receiverstate>
			<receiverpostcode>20857</receiverpostcode>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>+1301827</receivertel>
			<receivertelextension>0964</receivertelextension>
			<receivertelcountrycode>US</receivertelcountrycode>
			<receiverfax>+1301594</receiverfax>
			<receiverfaxextension>0829</receiverfaxextension>
			<receiverfaxcountrycode>US</receiverfaxcountrycode>
			<receiveremailaddress>.</receiveremailaddress>
		</receiver>
		<patient>
			<patientinitial>AMR</patientinitial>
			<patientinvestigationnumb>02</patientinvestigationnumb>
			<patientbirthdateformat>102</patientbirthdateformat>
			<patientbirthdate>19571211</patientbirthdate>
			<patientweight>58</patientweight>
			<patientheight>165</patientheight>
			<patientsex code="2">Female</patientsex>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Renal transplant</patientepisodename>
				<patientmedicalstartdateformat>102</patientmedicalstartdateformat>
				<patientmedicalstartdate>20111216</patientmedicalstartdate>
				<patientmedicalcontinue>3</patientmedicalcontinue>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Biopsy kidney</patientepisodename>
				<patientmedicalstartdateformat>102</patientmedicalstartdateformat>
				<patientmedicalstartdate>20120116</patientmedicalstartdate>
				<patientmedicalcontinue>3</patientmedicalcontinue>
				<patientmedicalcomment>Renal trasnplant biopsy.</patientmedicalcomment>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Mitral valve incompetence</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Hemiparesis</patientepisodename>
				<patientmedicalstartdateformat>102</patientmedicalstartdateformat>
				<patientmedicalstartdate>20120123</patientmedicalstartdate>
				<patientmedicalcontinue>3</patientmedicalcontinue>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Renal transplant</patientepisodename>
			</medicalhistoryepisode>
			<patientdeath>
				<patientdeathdateformat>102</patientdeathdateformat>
				<patientdeathdate>20120128</patientdeathdate>
				<patientautopsyyesno>3</patientautopsyyesno>
				<patientdeathcause>
					<patientdeathreportmeddraversion>15.1</patientdeathreportmeddraversion>
					<patientdeathreport>Cardiac arrest</patientdeathreport>
				</patientdeathcause>
				<patientdeathcause>
					<patientdeathreportmeddraversion>15.1</patientdeathreportmeddraversion>
					<patientdeathreport>Urinary tract infection</patientdeathreport>
				</patientdeathcause>
				<patientdeathcause>
					<patientdeathreportmeddraversion>15.1</patientdeathreportmeddraversion>
					<patientdeathreport>Septic shock</patientdeathreport>
				</patientdeathcause>
			</patientdeath>
			<reaction>
				<primarysourcereaction>Cardiac arrests</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Cardiac arrest</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Cardiac arrest</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionoutcome code="5">fatal</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Aspiration pneumonia</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Aspiration pneumonia</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Pneumonia aspiration</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20120123</reactionstartdate>
				<reactionfirsttime>39</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Septic shock</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Septic shock</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Septic shock</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20120128</reactionstartdate>
				<reactionfirsttime>290</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="5">fatal</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Urinary tract infection</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Urinary tract infection</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Urinary tract infection</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20120117</reactionstartdate>
				<reactionfirsttime>290</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="5">fatal</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Bacteremia</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Bacteremia</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Bacteraemia</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20120119</reactionstartdate>
				<reactionfirsttime>307</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="3">not recovered/not resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Left frontal Ischemic stroke due to heart disease (mitral regurgitation)</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Ischemic stroke</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Ischaemic stroke</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20120123</reactionstartdate>
				<reactionenddateformat>102</reactionenddateformat>
				<reactionenddate>20120126</reactionenddate>
				<reactionduration>4</reactionduration>
				<reactiondurationunit>804</reactiondurationunit>
				<reactionfirsttime>39</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="3">not recovered/not resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Renal dysfunction possibly due to dehydration/ Renal disfunction</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Kidney dysfunction</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Renal impairment</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20111230</reactionstartdate>
				<reactionfirsttime>15</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="4">recovered/resolved with sequelae</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Renal dysfunction possibly due to dehydration</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Dehydration</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Dehydration</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20111230</reactionstartdate>
				<reactionfirsttime>15</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="2">recovering/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Acute tubulointerstitial nephritis (moderate)</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Tubulointerstitial nephritis</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Tubulointerstitial nephritis</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20120126</reactionstartdate>
				<reactionfirsttime>42</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20111227</testdate>
				<testname>Blood creatinine</testname>
				<lowtestrange>0.7</lowtestrange>
				<hightestrange>1.3</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20111230</testdate>
				<testname>Blood creatinine</testname>
				<lowtestrange>0.7</lowtestrange>
				<hightestrange>1.3</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20111231</testdate>
				<testname>Blood creatinine</testname>
				<lowtestrange>0.7</lowtestrange>
				<hightestrange>1.3</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120116</testdate>
				<testname>Blood creatinine</testname>
				<lowtestrange>0.7</lowtestrange>
				<hightestrange>1.3</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120117</testdate>
				<testname>Blood creatinine</testname>
				<lowtestrange>0.7</lowtestrange>
				<hightestrange>1.3</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120120</testdate>
				<testname>Blood creatinine</testname>
				<lowtestrange>0.7</lowtestrange>
				<hightestrange>1.3</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120125</testdate>
				<testname>Blood creatinine</testname>
				<lowtestrange>0.7</lowtestrange>
				<hightestrange>1.3</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120126</testdate>
				<testname>Blood creatinine</testname>
				<lowtestrange>0.7</lowtestrange>
				<hightestrange>1.3</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testname>Blood culture</testname>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120117</testdate>
				<testname>Blood culture</testname>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testname>Chest X-ray</testname>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20111230</testdate>
				<testname>Chest X-ray</testname>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testname>Culture urine</testname>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20111230</testdate>
				<testname>Culture urine</testname>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120117</testdate>
				<testname>Culture urine</testname>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testname>Neutrophil count</testname>
				<testresult>90</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20111231</testdate>
				<testname>Neutrophil count</testname>
				<testresult>69</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testname>Pyrexia</testname>
				<testresult>39</testresult>
				<testunit>슰C</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testname>Pyrexia</testname>
				<testresult>39</testresult>
				<testunit>슰C</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120123</testdate>
				<testname>Scan brain</testname>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testname>Urinary sediment present</testname>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20111230</testdate>
				<testname>White blood cell count</testname>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20111231</testdate>
				<testname>White blood cell count</testname>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120116</testdate>
				<testname>White blood cell count</testname>
				<moreinformation>1</moreinformation>
			</test>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>MYFORTIC</medicinalproduct>
				<obtaindrugcountry>AR</obtaindrugcountry>
				<drugauthorizationnumb>50-791</drugauthorizationnumb>
				<drugauthorizationcountry>AR</drugauthorizationcountry>
				<drugauthorizationholder>NOVARTIS SECTOR: PHARMA</drugauthorizationholder>
				<drugstructuredosagenumb>720</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>2</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugcumulativedosagenumb>21600</drugcumulativedosagenumb>
				<drugcumulativedosageunit code="003">milligrams</drugcumulativedosageunit>
				<drugdosagetext>720 mg, BID</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Renal transplant</drugindication>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2011-12-16</drugstartdate>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2012-01-24</drugenddate>
				<drugtreatmentduration>40</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>MYCOPHENOLIC ACID</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Bacteraemia</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Bacteraemia</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Cardiac arrest</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Cardiac arrest</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Dehydration</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Dehydration</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Ischaemic stroke</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Ischaemic stroke</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pneumonia aspiration</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pneumonia aspiration</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Renal impairment</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Renal impairment</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Septic shock</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Septic shock</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Tubulointerstitial nephritis</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Tubulointerstitial nephritis</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Urinary tract infection</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Urinary tract infection</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct> PROGRAF</medicinalproduct>
				<obtaindrugcountry>AR</obtaindrugcountry>
				<drugauthorizationcountry>AR</drugauthorizationcountry>
				<drugstructuredosagenumb>4</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>2</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>4 mg, BID</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Renal transplant</drugindication>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2011-12-16</drugstartdate>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2012-01-25</drugenddate>
				<drugtreatmentduration>41</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>TACROLIMUS</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Bacteraemia</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Bacteraemia</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Cardiac arrest</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Cardiac arrest</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Dehydration</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Dehydration</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Ischaemic stroke</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Ischaemic stroke</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pneumonia aspiration</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pneumonia aspiration</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Renal impairment</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Renal impairment</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Septic shock</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Septic shock</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Tubulointerstitial nephritis</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Tubulointerstitial nephritis</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Urinary tract infection</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Urinary tract infection</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct> PROGRAF</medicinalproduct>
				<obtaindrugcountry>AR</obtaindrugcountry>
				<drugauthorizationcountry>AR</drugauthorizationcountry>
				<drugstructuredosagenumb>10</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugdosagetext>10 mg, UNK</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>TACROLIMUS</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Bacteraemia</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Bacteraemia</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Cardiac arrest</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Cardiac arrest</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Dehydration</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Dehydration</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Ischaemic stroke</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Ischaemic stroke</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pneumonia aspiration</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pneumonia aspiration</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Renal impairment</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Renal impairment</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Septic shock</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Septic shock</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Tubulointerstitial nephritis</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Tubulointerstitial nephritis</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Urinary tract infection</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Urinary tract infection</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>NEORAL </medicinalproduct>
				<obtaindrugcountry>AR</obtaindrugcountry>
				<drugauthorizationcountry>AR</drugauthorizationcountry>
				<drugdosagetext>UNK</drugdosagetext>
				<drugdosageform normalized="capsule">Capsule</drugdosageform>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Renal transplant</drugindication>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2012-01-26</drugstartdate>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>CICLOSPORIN</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Bacteraemia</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Bacteraemia</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Cardiac arrest</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Cardiac arrest</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Dehydration</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Dehydration</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Ischaemic stroke</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Ischaemic stroke</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pneumonia aspiration</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pneumonia aspiration</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Renal impairment</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Renal impairment</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Septic shock</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Septic shock</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Tubulointerstitial nephritis</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Tubulointerstitial nephritis</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Urinary tract infection</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Urinary tract infection</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<summary>
				<narrativeincludeclinical>Case number PHHO2011AR021780, is an <Semaphore x="1938518" class="Disease or Finding" value="First-Degree Burn" score="1.00" ID="C76130">initial </Semaphore>report received on 30 Dec 2011, from clinical study CRAD001A2429. This 54-year old female subject [centre number 0141, subject number 02] was enrolled in a 24-month, multi center, open label, randomized, <Semaphore x="1854518" class="Disease or Finding" value="Disease Controlled" score="1.00" ID="C82500">controlled </Semaphore>trial to investigate efficacy, safety and evolution of <Semaphore x="1726192" class="AnatomicStructure" value="Cardiovascular System" score="1.00" ID="C12686">cardiovascular </Semaphore>parameters in de novo <Semaphore x="3228018" class="MedDRA LLT" value="Renal transplant" score="1.00" ID="10038533">renal <Semaphore x="1992543" class="AnatomicStructure" value="Graft" score="1.00" ID="C12981">transplant </Semaphore></Semaphore>recipients after early calcineurin inhibitor to <Semaphore x="558929" class="Medicine" value="everolimus" score="0.49" ID="232653">everolimus </Semaphore>conversion.Concomitant medication included <Semaphore x="894874" class="Medicine" value="Myfortic" score="0.93" ID="275245">Myfortic</Semaphore>. On 16 Dec 2011, the subject underwent cadaveric <Semaphore x="3228018" class="MedDRA LLT" value="Renal transplant" score="1.00" ID="10038533">renal <Semaphore x="1992543" class="AnatomicStructure" value="Graft" score="1.00" ID="C12981">transplant</Semaphore></Semaphore>. On the same day, the subject started the study medications (<Semaphore x="1244668" class="Medicine" value="Tacrolimus" score="0.98" ID="268063">tacrolimus</Semaphore>) at a dose of 04 mg BID. The subject had no complications of <Semaphore x="3228018" class="MedDRA LLT" value="Renal transplant" score="1.00" ID="10038533">renal <Semaphore x="1992543" class="AnatomicStructure" value="Graft" score="1.00" ID="C12981">transplant </Semaphore></Semaphore>and was discharged on 27 Dec 2011 with <Semaphore x="1821896" class="Procedure" value="Creatinine Measurement" score="1.00" ID="C64547">creatinine </Semaphore>1.28 mg/dl. On 30 Dec 2011, the subject experienced renal dysfunction and <Semaphore x="2110342" class="Disease or Finding" value="Leukocytosis" score="1.00" ID="C35524">leukocytosis</Semaphore>. On unspecified date, the subject was re hospitalized, <Semaphore x="1821896" class="Procedure" value="Creatinine Measurement" score="1.00" ID="C64547">creatinine </Semaphore>was 1.8 mg/dl and <Semaphore x="2699001" class="Race" value="White" score="1.00" ID="C41261">white </Semaphore><Semaphore x="1734573" class="Procedure" value="Cell Count" score="1.00" ID="C48938">cell </Semaphore>
    <Semaphore x="1734573" class="Procedure" value="Cell Count" score="1.00" ID="C48938">count </Semaphore>was 19.000, <Semaphore x="2889895" class="MedDRA LLT" value="Culture urine negative" score="1.00" ID="10011639"><Semaphore x="2671993" class="AnatomicStructure" value="Urinary System" score="1.00" ID="C12413">urine </Semaphore>culture <Semaphore x="1910095" class="Disease or Finding" value="Experimental Result" score="1.00" ID="C76125">resulted </Semaphore><Semaphore x="2265745" class="Disease or Finding" value="Negative Patch Test" score="1.00" ID="C35633">negative </Semaphore></Semaphore>and <Semaphore x="1762050" class="AnatomicStructure" value="Chest" score="1.00" ID="C25389">chest </Semaphore>radiograph was normal. The subject was on <Semaphore x="2377095" class="Procedure" value="Parenteral Therapeutic Nutritional Supplementation" score="1.00" ID="C67019">parenteral </Semaphore>hydration (<Semaphore x="933272" class="Medicine" value="Normal saline" score="0.49" ID="216804">normal saline </Semaphore>solution) from 30 Dec 2011 to 31 Dec 2011. On that date, <Semaphore x="3057951" class="MedDRA LLT" value="Laboratory test" score="1.00" ID="10059938">laboratory tests </Semaphore>performed showed <Semaphore x="1821896" class="Procedure" value="Creatinine Measurement" score="1.00" ID="C64547">creatinine </Semaphore>1.24 mg/dl, <Semaphore x="2699001" class="Race" value="White" score="1.00" ID="C41261">white </Semaphore><Semaphore x="1734573" class="Procedure" value="Cell Count" score="1.00" ID="C48938">cell </Semaphore>
    <Semaphore x="1734573" class="Procedure" value="Cell Count" score="1.00" ID="C48938">count </Semaphore>11000 and <Semaphore x="1410372" class="Procedure" value="Absolute Neutrophil Count" score="1.00" ID="C63321">neutrophils </Semaphore>fraction 69%. The subject remained without <Semaphore x="1932946" class="Disease or Finding" value="Fever" score="1.00" ID="C3038">fever</Semaphore>. The <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>for events was reported as condition improving. On 31 Dec 2011, the subject was discharged from hospital. The subject received <Semaphore x="1863405" class="Procedure" value="Dose Increased" score="1.00" ID="C49503">increased dose </Semaphore>(10 mg) of study medication (<Semaphore x="1244668" class="Medicine" value="Tacrolimus" score="0.98" ID="268063">Tacrolimus</Semaphore>) (date unspecified). On 16 Jan 2012, the subject was hospitalized to <Semaphore x="1010955" class="Medicine" value="Perform" score="0.49" ID="188526">perform </Semaphore><Semaphore x="2087096" class="Procedure" value="Kidney Biopsy" score="1.00" ID="C51699"><Semaphore x="3228018" class="MedDRA LLT" value="Renal transplant" score="1.00" ID="10038533">renal <Semaphore x="1992543" class="AnatomicStructure" value="Graft" score="1.00" ID="C12981">transplant </Semaphore></Semaphore>biopsy due to renal </Semaphore>dysfunction (second occurrence). On the same date, <Semaphore x="1821896" class="Procedure" value="Creatinine Measurement" score="1.00" ID="C64547">creatinine </Semaphore>was 2 mg/dl and <Semaphore x="2699001" class="Race" value="White" score="1.00" ID="C41261">white </Semaphore><Semaphore x="1734573" class="Procedure" value="Cell Count" score="1.00" ID="C48938">cell </Semaphore>
    <Semaphore x="1734573" class="Procedure" value="Cell Count" score="1.00" ID="C48938">count </Semaphore>was 13800u/mm3. <Semaphore x="2614087" class="AnatomicStructure" value="Thorax" score="1.00" ID="C12799">Thorax </Semaphore><Semaphore x="1846391" class="Procedure" value="Diagnostic Imaging" score="0.58" ID="C16502">X ray </Semaphore>
    <Semaphore x="3324688" class="MedDRA LLT" value="X-ray normal" score="1.00" ID="10048067">was normal</Semaphore>. On 16 Jan 2012, the subject started with <Semaphore x="1932946" class="Disease or Finding" value="Fever" score="1.00" ID="C3038">fever </Semaphore>and <Semaphore x="2110342" class="Disease or Finding" value="Leukocytosis" score="1.00" ID="C35524">leukocytosis</Semaphore>, without any clear source of <Semaphore x="3033151" class="MedDRA LLT" value="Infection" score="1.00" ID="10021789">infection</Semaphore>. On 17 Jan 2012, <Semaphore x="1821896" class="Procedure" value="Creatinine Measurement" score="1.00" ID="C64547">creatinine </Semaphore>raised to 2.11 mg/dl and <Semaphore x="2671993" class="AnatomicStructure" value="Urinary System" score="1.00" ID="C12413">urinary </Semaphore>and <Semaphore x="2804598" class="MedDRA LLT" value="Blood culture" score="1.00" ID="10005485"><Semaphore x="1608509" class="AnatomicStructure" value="Blood" score="1.00" ID="C12434">blood </Semaphore>culture </Semaphore>were performed and <Semaphore x="1910095" class="Disease or Finding" value="Experimental Result" score="1.00" ID="C76125">resulted </Semaphore>positive to <Semaphore x="3191772" class="MedDRA LLT" value="Pneumonia klebsiella" score="1.00" ID="10035717">Klebsiella <Semaphore x="2411042" class="Disease or Finding" value="Pneumonia" score="1.00" ID="C3333">pneumonia</Semaphore></Semaphore>. On the same date, the subject started <Semaphore x="316759" class="Medicine" value="Ceftazidime" score="0.49" ID="248750">Ceftazidime </Semaphore><Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment</Semaphore>. On 19 Jan 2012, the subject started intravenous <Semaphore x="699721" class="Medicine" value="Imipenem" score="0.49" ID="271826">Imipenem </Semaphore>(<Semaphore x="2737985" class="MedDRA LLT" value="Analgesic drug level" score="1.00" ID="10060090">paracetamol</Semaphore>). On 20 Jan 2012, <Semaphore x="1821896" class="Procedure" value="Creatinine Measurement" score="1.00" ID="C64547">creatinine </Semaphore>was 3.75 mg/dl. On 23 Jan 2012, the subject presented right faciobrachial crural hemiparesia. On the same date, <Semaphore x="2871613" class="MedDRA LLT" value="Computerised tomogram head" score="1.00" ID="10054003"><Semaphore x="1629793" class="AnatomicStructure" value="Brain" score="1.00" ID="C12439">brain </Semaphore><Semaphore x="2871950" class="MedDRA LLT" value="Computerised tomogram" score="1.00" ID="10010234">CT </Semaphore>
     <Semaphore x="2871950" class="MedDRA LLT" value="Computerised tomogram" score="1.00" ID="10010234">(computerized <Semaphore x="1804944" class="Procedure" value="Computed Tomography" score="1.00" ID="C17204">tomography</Semaphore>) <Semaphore x="1846391" class="Procedure" value="Diagnostic Imaging" score="0.58" ID="C16502">scan </Semaphore></Semaphore></Semaphore>performed reported left frontal <Semaphore x="2080997" class="Disease or Finding" value="Ischemic Cerebrovascular Accident" score="1.00" ID="C95802">ischemic stroke </Semaphore>(hypodense <Semaphore x="2107425" class="Disease or Finding" value="Lesion" score="1.00" ID="C3824">lesion </Semaphore>in left frontal region). On 23 Jan 2012, the subject presented with <Semaphore x="1549376" class="Procedure" value="Aspiration of Breast" score="1.00" ID="C51634">aspiration pneumonia</Semaphore>. On unspecified date, the subject was moved to <Semaphore x="2060498" class="Procedure" value="Intensive Phase" score="1.00" ID="C85515">ICU </Semaphore>(<Semaphore x="3043968" class="MedDRA LLT" value="Intensive care" score="1.00" ID="10022519">intensive care </Semaphore>unit), the <Semaphore x="1932946" class="Disease or Finding" value="Fever" score="1.00" ID="C3038">fever </Semaphore>persisted and <Semaphore x="1321586" class="Medicine" value="Vancomycin" score="0.49" ID="195432">vancomycin </Semaphore>and <Semaphore x="870076" class="Medicine" value="metroNIDAZOLE" score="0.49" ID="280143">metronidazole </Semaphore>were added to <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment</Semaphore>. The investigator reported that the subject had many compliance problems with study medication and it was decided to interrupt the <Semaphore x="2394286" class="Procedure" value="Pharmacotherapy" score="1.00" ID="C15986">treatment with study medication</Semaphore>. On 24 Jan 2012, the subject took the last dose of <Semaphore x="894874" class="Medicine" value="Myfortic" score="0.93" ID="275245">Myfortic </Semaphore>and the last dose of <Semaphore x="1244668" class="Medicine" value="Tacrolimus" score="0.98" ID="268063">Tacrolimus </Semaphore>on 25 Jan 2012. On that date, <Semaphore x="1821896" class="Procedure" value="Creatinine Measurement" score="1.00" ID="C64547">creatinine </Semaphore>improved to 1.49 mg/dl and renal function improved. On 26 Jan 2012, the subject presented with <Semaphore x="3138406" class="MedDRA LLT" value="Nephritis" score="1.00" ID="10029117">acute <Semaphore x="3290660" class="MedDRA LLT" value="Tubulointerstitial nephritis" score="1.00" ID="10048302">tubulointerstitial <Semaphore x="2294143" class="Disease or Finding" value="Nephritis" score="1.00" ID="C26833">nephritis </Semaphore></Semaphore></Semaphore>(moderate). On 26 Jan 2012, <Semaphore x="1821896" class="Procedure" value="Creatinine Measurement" score="1.00" ID="C64547">creatinine </Semaphore>was 1.55 mg/dl. On that date, the subject was considered recovered with sequelae from <Semaphore x="2080997" class="Disease or Finding" value="Ischemic Cerebrovascular Accident" score="1.00" ID="C95802">ischemic stroke </Semaphore>(the subject had a mild improving neurological condition with stable hemodynamic profile). The subject switched the study medication <Semaphore x="1244668" class="Medicine" value="Tacrolimus" score="0.98" ID="268063">Tacrolimus </Semaphore>to <Semaphore x="913401" class="Medicine" value="Neoral" score="0.97" ID="241343">Neoral </Semaphore>on 26 Jan 2012. On 28 Jan 2012, the subject received the last dose of the study medication (<Semaphore x="913401" class="Medicine" value="Neoral" score="0.97" ID="241343">Neoral</Semaphore>). At the time of the report, the subject was improving from <Semaphore x="1563562" class="Disease or Finding" value="Bacteremia" score="1.00" ID="C102993">bacteremia </Semaphore>and <Semaphore x="1409602" class="Procedure" value="About What Time is it" score="1.00" ID="C110931">unchanged </Semaphore>from <Semaphore x="2080997" class="Disease or Finding" value="Ischemic Cerebrovascular Accident" score="1.00" ID="C95802">ischemic stroke</Semaphore>. The subject recovered with sequelae from renal dysfunction. On 28 Jan 2012, the subject experienced <Semaphore x="2505614" class="Disease or Finding" value="Septic Shock" score="1.00" ID="C35018">septic shock</Semaphore>. On the same day, the subject died due to <Semaphore x="2672555" class="Disease or Finding" value="Urinary Tract Infection" score="1.00" ID="C50791">urinary tract infection </Semaphore>and <Semaphore x="2505614" class="Disease or Finding" value="Septic Shock" score="1.00" ID="C35018">septic shock</Semaphore>. The investigator reported that the according to <Semaphore x="1728496" class="Disease or Finding" value="Cause of Death" score="1.00" ID="C81239"><Semaphore x="2895537" class="MedDRA LLT" value="Death" score="1.00" ID="10011906">death </Semaphore>certificate, the cause of <Semaphore x="1722642" class="Disease or Finding" value="Cardiac Death" score="1.00" ID="C54196">death </Semaphore></Semaphore>
    <Semaphore x="2840449" class="MedDRA LLT" value="Cardiac death" score="1.00" ID="10049993">
     <Semaphore x="1837270" class="Disease or Finding" value="Death" score="1.00" ID="C28554">
      <Semaphore x="1722642" class="Disease or Finding" value="Cardiac Death" score="1.00" ID="C54196">was <Semaphore x="1722367" class="Disease or Finding" value="Cardiac Arrest" score="1.00" ID="C50479">cardiac </Semaphore></Semaphore>
      <Semaphore x="2840299" class="MedDRA LLT" value="Cardiac arrest" score="1.00" ID="10007515">
       </Semaphore></Semaphore>
     <Semaphore x="2840299" class="MedDRA LLT" value="Cardiac arrest" score="1.00" ID="10007515">
      </Semaphore></Semaphore>
    <Semaphore x="2840299" class="MedDRA LLT" value="Cardiac arrest" score="1.00" ID="10007515">
     <Semaphore x="1722367" class="Disease or Finding" value="Cardiac Arrest" score="1.00" ID="C50479">arrests</Semaphore></Semaphore>. The investigator confirmed that an <Semaphore x="1558453" class="Disease or Finding" value="Autopsy TNM Finding" score="1.00" ID="C48882">autopsy </Semaphore>was not performed. The events were considered as serious by the investigator <Semaphore x="1563562" class="Disease or Finding" value="Bacteremia" score="1.00" ID="C102993">bacteremia </Semaphore>and <Semaphore x="2080997" class="Disease or Finding" value="Ischemic Cerebrovascular Accident" score="1.00" ID="C95802">ischemic stroke </Semaphore>(life threatening), renal dysfunction (both occurrences) (<Semaphore x="3012166" class="MedDRA LLT" value="Hospitalisation" score="1.00" ID="10054112">hospitalisation</Semaphore>)<Semaphore x="2672555" class="Disease or Finding" value="Urinary Tract Infection" score="1.00" ID="C50791">, <Semaphore x="2672555" class="Disease or Finding" value="Urinary Tract Infection" score="1.00" ID="C50791">urinary tract infection </Semaphore></Semaphore>as serious (fatal and life threatening)<Semaphore x="2505614" class="Disease or Finding" value="Septic Shock" score="1.00" ID="C35018">, <Semaphore x="2505614" class="Disease or Finding" value="Septic Shock" score="1.00" ID="C35018">septic shock </Semaphore></Semaphore>and <Semaphore x="1722367" class="Disease or Finding" value="Cardiac Arrest" score="1.00" ID="C50479">cardiac arrests </Semaphore>as serious (Fatal). In the absence of investigator's seriousness criteria, Novartis safety <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>assessed the event <Semaphore x="1549376" class="Procedure" value="Aspiration of Breast" score="1.00" ID="C51634">aspiration pneumonia </Semaphore>as serious (<Semaphore x="3012166" class="MedDRA LLT" value="Hospitalisation" score="1.00" ID="10054112">hospitalization</Semaphore>). The event of <Semaphore x="3290660" class="MedDRA LLT" value="Tubulointerstitial nephritis" score="1.00" ID="10048302">tubulointerstitial <Semaphore x="2294143" class="Disease or Finding" value="Nephritis" score="1.00" ID="C26833">nephritis </Semaphore></Semaphore>was considered as serious (medically significant) by the investigator.The investigator did not suspect relationship between the events <Semaphore x="1563562" class="Disease or Finding" value="Bacteremia" score="1.00" ID="C102993">bacteremia</Semaphore>, <Semaphore x="2080997" class="Disease or Finding" value="Ischemic Cerebrovascular Accident" score="1.00" ID="C95802">ischemic stroke</Semaphore>, renal dysfunction possibly due to <Semaphore x="1839429" class="Disease or Finding" value="Dehydration Polycythemia" score="1.00" ID="C27310">dehydration</Semaphore><Semaphore x="2505614" class="Disease or Finding" value="Septic Shock" score="1.00" ID="C35018">, <Semaphore x="2505614" class="Disease or Finding" value="Septic Shock" score="1.00" ID="C35018">septic shock </Semaphore></Semaphore>and <Semaphore x="2672555" class="Disease or Finding" value="Urinary Tract Infection" score="1.00" ID="C50791">urinary tract infection </Semaphore>and the study medication (<Semaphore x="1244668" class="Medicine" value="Tacrolimus" score="0.98" ID="268063">tacrolimus </Semaphore>and <Semaphore x="894874" class="Medicine" value="Myfortic" score="0.93" ID="275245">Myfortic</Semaphore>). The investigator suspected a relation between the events (<Semaphore x="1722367" class="Disease or Finding" value="Cardiac Arrest" score="1.00" ID="C50479"><Semaphore x="1722367" class="Disease or Finding" value="Cardiac Arrest" score="1.00" ID="C50479">cardiac arrests</Semaphore>, </Semaphore><Semaphore x="1549376" class="Procedure" value="Aspiration of Breast" score="1.00" ID="C51634">aspiration pneumonia</Semaphore>) and the study medications (<Semaphore x="913401" class="Medicine" value="Neoral" score="0.97" ID="241343">Neoral</Semaphore>, <Semaphore x="1244668" class="Medicine" value="Tacrolimus" score="0.98" ID="268063">Tacrolimus </Semaphore>and <Semaphore x="894874" class="Medicine" value="Myfortic" score="0.93" ID="275245">Myfortic</Semaphore>). In the absence of investigator causality the events <Semaphore x="1722367" class="Disease or Finding" value="Cardiac Arrest" score="1.00" ID="C50479">cardiac arrest </Semaphore>and <Semaphore x="2505614" class="Disease or Finding" value="Septic Shock" score="1.00" ID="C35018">septic shock </Semaphore>were considered as suspected to <Semaphore x="913401" class="Medicine" value="Neoral" score="0.97" ID="241343">Neoral </Semaphore>for reporting purpose. The event renal dysfunction (both occurrences) was reportedly due to <Semaphore x="1839429" class="Disease or Finding" value="Dehydration Polycythemia" score="1.00" ID="C27310">dehydration </Semaphore>and the event left frontal <Semaphore x="2080997" class="Disease or Finding" value="Ischemic Cerebrovascular Accident" score="1.00" ID="C95802">Ischemic stroke </Semaphore>due to <Semaphore x="2010014" class="Disease or Finding" value="Heart Disorder" score="1.00" ID="C3079">heart disease </Semaphore>(<Semaphore x="3111486" class="MedDRA LLT" value="Mitral valve incompetence" score="1.00" ID="10027727">mitral regurgitation</Semaphore>). The investigator did not suspect any relationship between the event of <Semaphore x="3138406" class="MedDRA LLT" value="Nephritis" score="1.00" ID="10029117">acute <Semaphore x="3290660" class="MedDRA LLT" value="Tubulointerstitial nephritis" score="1.00" ID="10048302">tubulointerstitial <Semaphore x="2294143" class="Disease or Finding" value="Nephritis" score="1.00" ID="C26833">nephritis </Semaphore></Semaphore></Semaphore>and the study medications.Follow up received on 17 Jan 2012: Added event <Semaphore x="1839429" class="Disease or Finding" value="Dehydration Polycythemia" score="1.00" ID="C27310">dehydration </Semaphore>and <Semaphore x="1932946" class="Disease or Finding" value="Fever" score="1.00" ID="C3038">fever</Semaphore>, updated laboratory information, <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore><Semaphore x="1670730" class="Procedure" value="CAM Pharmacological or Biological Treatment" score="1.00" ID="C15906">drugs</Semaphore>, event <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>and discharge date.Follow up received on 26 Jan 2012, prior to <Semaphore x="1607047" class="Disease or Finding" value="Blood Clot" score="1.00" ID="C27083">circulation </Semaphore>of previous report: Added events <Semaphore x="2672555" class="Disease or Finding" value="Urinary Tract Infection" score="1.00" ID="C50791"><Semaphore x="2672555" class="Disease or Finding" value="Urinary Tract Infection" score="1.00" ID="C50791">urinary tract infection</Semaphore>, </Semaphore><Semaphore x="1563562" class="Disease or Finding" value="Bacteremia" score="1.00" ID="C102993">bacteremia </Semaphore>and <Semaphore x="2080997" class="Disease or Finding" value="Ischemic Cerebrovascular Accident" score="1.00" ID="C95802">ischemic stroke</Semaphore>. Updated <Semaphore x="3057951" class="MedDRA LLT" value="Laboratory test" score="1.00" ID="10059938">laboratory tests</Semaphore>, <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment</Semaphore>, events <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>and seriousness criteria.Follow up report received on 19 Apr 2012: Updated additional events of <Semaphore x="2505614" class="Disease or Finding" value="Septic Shock" score="1.00" ID="C35018"><Semaphore x="2505614" class="Disease or Finding" value="Septic Shock" score="1.00" ID="C35018">septic shock</Semaphore>, </Semaphore><Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome</Semaphore>, <Semaphore x="1558453" class="Disease or Finding" value="Autopsy TNM Finding" score="1.00" ID="C48882">autopsy </Semaphore>details, seriousness and causality.Follow up (<Semaphore x="1862781" class="Race" value="Dominican" score="1.00" ID="C67117">DR</Semaphore>) received on 05 Jun 2012: Updated causality of the event <Semaphore x="2505614" class="Disease or Finding" value="Septic Shock" score="1.00" ID="C35018">septic shock </Semaphore>(not suspected to study medication).Follow up received on 25 Jul 2012: Updated study medication (<Semaphore x="913401" class="Medicine" value="Neoral" score="0.97" ID="241343">Neoral</Semaphore>) information, causality and <Semaphore x="1728496" class="Disease or Finding" value="Cause of Death" score="1.00" ID="C81239">cause of <Semaphore x="2895537" class="MedDRA LLT" value="Death" score="1.00" ID="10011906">death </Semaphore></Semaphore>as per <Semaphore x="1837270" class="Disease or Finding" value="Death" score="1.00" ID="C28554">death </Semaphore>certificate with <Semaphore x="1558453" class="Disease or Finding" value="Autopsy TNM Finding" score="1.00" ID="C48882">autopsy </Semaphore>details.Follow up data reconciliation report received on 20 Nov 2012: Updated new event (<Semaphore x="1549376" class="Procedure" value="Aspiration of Breast" score="1.00" ID="C51634">aspiration pneumonia</Semaphore>).Follow up data reconciliation report received on 22 Nov 2012: Updated date of <Semaphore x="1837270" class="Disease or Finding" value="Death" score="1.00" ID="C28554">death </Semaphore>in the case.Follow up data reconciliation report received on 23 Nov 2012, prior to the <Semaphore x="1607047" class="Disease or Finding" value="Blood Clot" score="1.00" ID="C27083">circulation </Semaphore>of the previous report on 22 Nov 2012: Upadted new diagnsis (<Semaphore x="3138406" class="MedDRA LLT" value="Nephritis" score="1.00" ID="10029117">acute <Semaphore x="3290660" class="MedDRA LLT" value="Tubulointerstitial nephritis" score="1.00" ID="10048302">tubulointerstitial <Semaphore x="2294143" class="Disease or Finding" value="Nephritis" score="1.00" ID="C26833">nephritis</Semaphore></Semaphore></Semaphore>) with onset, seriousness, causality and <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome</Semaphore>.Follow up <Semaphore x="1862781" class="Race" value="Dominican" score="1.00" ID="C67117">DR </Semaphore>received on 10 Dec 2012: Updated onset date of event septick <Semaphore x="2519103" class="Disease or Finding" value="Shock" score="1.00" ID="C35016">shock</Semaphore>.</narrativeincludeclinical>
				<sendercomment>For Prograf:
Serious adverse drug reaction aspiration pneumonia, (medically significant), assessed as unlisted according to the Summary of product characteristics. Investigator causality is suspected.

Serious adverse drug reaction report, cardiac arrest (fatal), assessed as unlisted according to the Summary of product characteristics. Investigator causality is suspected.

MR comment:
Based on review of available reported data, Novartis agrees with the investigator's causality for the reported events Urinary tract infection, Bacteremia, Ischemic stroke, Kidney dysfunction, and Dehydration as not suspected for all the suspected drugs, and Septic Shock as not suspected for mycophenolic acid and tacrolimus. Based on the available reported minimal information on the exact details of the event Cardiac arrest, the event is currently unassessable. The case will be reassessed when additional information becomes available.</sendercomment>
			</summary>
		</patient>
	</safetyreport>
</ichicsr></original></faers>